Jesús Chamorro

438 total citations
11 papers, 231 citations indexed

About

Jesús Chamorro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jesús Chamorro has authored 11 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Jesús Chamorro's work include Sarcoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Jesús Chamorro is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Jesús Chamorro collaborates with scholars based in Spain and United Kingdom. Jesús Chamorro's co-authors include Víctor Albarrán, Diana Isabel Rosero, María San Román, Javier Pozas, Ainara Soria, J.C. Calvo, Pablo Gajate, Jaime A. Moreno, L. Ley and M Del Campo Martín and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Jesús Chamorro

11 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Chamorro Spain 8 108 88 71 50 43 11 231
Nicholas Coupe United Kingdom 7 139 1.3× 43 0.5× 72 1.0× 16 0.3× 60 1.4× 19 220
Tristan Lerbs United States 7 51 0.5× 67 0.8× 97 1.4× 26 0.5× 62 1.4× 8 233
Yumiko Higuchi Japan 10 167 1.5× 48 0.5× 92 1.3× 54 1.1× 166 3.9× 30 305
Huanzhang Li China 6 94 0.9× 29 0.3× 40 0.6× 25 0.5× 65 1.5× 14 206
Katarína Múčková Czechia 7 142 1.3× 31 0.4× 74 1.0× 66 1.3× 122 2.8× 13 323
Galam Leem South Korea 11 166 1.5× 50 0.6× 67 0.9× 12 0.2× 107 2.5× 23 321
Tingyue Zhou China 9 118 1.1× 22 0.3× 133 1.9× 27 0.5× 126 2.9× 9 306
Sarah E. Arthur Canada 6 57 0.5× 41 0.5× 71 1.0× 35 0.7× 31 0.7× 11 198
Ahmed Raji Iraq 3 204 1.9× 68 0.8× 97 1.4× 10 0.2× 132 3.1× 8 319
Aileen Ryan United States 9 173 1.6× 50 0.6× 45 0.6× 96 1.9× 106 2.5× 21 230

Countries citing papers authored by Jesús Chamorro

Since Specialization
Citations

This map shows the geographic impact of Jesús Chamorro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Chamorro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Chamorro more than expected).

Fields of papers citing papers by Jesús Chamorro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Chamorro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Chamorro. The network helps show where Jesús Chamorro may publish in the future.

Co-authorship network of co-authors of Jesús Chamorro

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Chamorro. A scholar is included among the top collaborators of Jesús Chamorro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Chamorro. Jesús Chamorro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Albarrán, Víctor, María San Román, Javier Pozas, et al.. (2024). Adoptive T cell therapy for solid tumors: current landscape and future challenges. Frontiers in Immunology. 15. 1352805–1352805. 37 indexed citations
2.
3.
Albarrán, Víctor, María San Román, Jaime A. Moreno, et al.. (2023). BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. Cancers. 15(21). 5243–5243. 9 indexed citations
4.
García-Donás, Jesús, Guillermo de Velasco, Rodrigo Madurga, et al.. (2023). Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study. Clinical & Translational Oncology. 26(3). 732–738. 1 indexed citations
5.
Albarrán, Víctor, Jesús Chamorro, Javier Pozas, et al.. (2023). Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature. Frontiers in Oncology. 13. 1158981–1158981. 3 indexed citations
6.
Albarrán, Víctor, et al.. (2023). Recurrent Glioblastoma: A Review of the Treatment Options. Cancers. 15(17). 4279–4279. 60 indexed citations
7.
Albarrán, Víctor, Javier Pozas, Jesús Chamorro, et al.. (2023). Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers. 15(8). 2287–2287. 13 indexed citations
8.
Albarrán, Víctor, Jesús Chamorro, Diana Isabel Rosero, et al.. (2022). Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature. Frontiers in Pharmacology. 13. 774170–774170. 36 indexed citations
9.
Albarrán, Víctor, Jesús Chamorro, Diana Isabel Rosero, et al.. (2022). Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas. International Journal of Molecular Sciences. 23(22). 13784–13784. 23 indexed citations
10.
Norman, Francesca, et al.. (2021). Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era. Journal of Travel Medicine. 29(1). 8 indexed citations
11.
Chamorro, Jesús, María San Román, Javier Pozas, et al.. (2021). Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma. Cancers. 13(23). 5981–5981. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Coupe Breakdown of academic impact, for papers by Tristan Lerbs Breakdown of academic impact, for papers by Yumiko Higuchi Breakdown of academic impact, for papers by Huanzhang Li Breakdown of academic impact, for papers by Katarína Múčková Breakdown of academic impact, for papers by Galam Leem Breakdown of academic impact, for papers by Tingyue Zhou Breakdown of academic impact, for papers by Sarah E. Arthur Breakdown of academic impact, for papers by Ahmed Raji Breakdown of academic impact, for papers by Aileen Ryan
Rankless by CCL
2026